{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:58:00Z","timestamp":1789747080503,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2021108003"],"award-info":[{"award-number":["H2021108003"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12033-024-01061-5","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T19:02:41Z","timestamp":1707418961000},"page":"496-509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Integrin \u03b24 Regulates Cell Migration of Lung Adenocarcinoma Through FAK Signaling"],"prefix":"10.1007","volume":"67","author":[{"given":"Shusen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuecong","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9472-1591","authenticated-orcid":false,"given":"Shubo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2190-4928","authenticated-orcid":false,"given":"Zhigang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"issue":"10299","key":"1061_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai, A. A., Solomon, B. J., Sequist, L. V., Gainor, J. F., & Heist, R. S. (2021). Lung cancer. The Lancet, 398(10299), 535\u2013554.","journal-title":"The Lancet"},{"key":"1061_CR2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10147-021-02108-2","volume":"27","author":"R Sharma","year":"2022","unstructured":"Sharma, R. (2022). Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050. International Journal of Clinical Oncology, 27, 665.","journal-title":"International Journal of Clinical Oncology"},{"issue":"1","key":"1061_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","volume":"41","author":"BC Bade","year":"2020","unstructured":"Bade, B. C., & Dela Cruz, C. S. (2020). Lung cancer 2020: Epidemiology, etiology, and prevention. Clinics in Chest Medicine, 41(1), 1\u201324.","journal-title":"Clinics in Chest Medicine"},{"issue":"6","key":"1061_CR4","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1158\/2159-8290.CD-20-1274","volume":"11","author":"D Tavernari","year":"2021","unstructured":"Tavernari, D., Battistello, E., Dheilly, E., Petruzzella, A. S., Mina, M., Sordet-Dessimoz, J., Peters, S., Krueger, T., Gfeller, D., Riggi, N., Oricchio, E., Letovanec, I., & Ciriello, G. (2021). Nongenetic evolution drives lung adenocarcinoma spatial heterogeneity and progression. Cancer Discovery, 11(6), 1490\u20131507.","journal-title":"Cancer Discovery"},{"issue":"7","key":"1061_CR5","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.21037\/jtd.2017.06.20","volume":"9","author":"R Chalela","year":"2017","unstructured":"Chalela, R., Curull, V., Enriquez, C., Pijuan, L., Bellosillo, B., & Gea, J. (2017). Lung adenocarcinoma: From molecular basis to genome-guided therapy and immunotherapy. Journal of Thoracic Disease, 9(7), 2142\u20132158.","journal-title":"Journal of Thoracic Disease"},{"issue":"1","key":"1061_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cell.2020.05.043","volume":"182","author":"JY Xu","year":"2020","unstructured":"Xu, J. Y., Zhang, C., Wang, X., Zhai, L., Ma, Y., Mao, Y., Qian, K., Sun, C., Liu, Z., Jiang, S., Wang, M., Feng, L., Zhao, L., Liu, P., Wang, B., Zhao, X., Xie, H., Yang, X., Zhao, L., \u2026 Tan, M. (2020). Integrative proteomic characterization of human lung adenocarcinoma. Cell, 182(1), 245\u2013261.","journal-title":"Cell"},{"issue":"2","key":"1061_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/CCO.0000000000000429","volume":"30","author":"F Oberndorfer","year":"2018","unstructured":"Oberndorfer, F., & Mullauer, L. (2018). Molecular pathology of lung cancer: Current status and perspectives. Current Opinion in Oncology, 30(2), 69\u201376.","journal-title":"Current Opinion in Oncology"},{"issue":"10","key":"1061_CR8","doi-asserted-by":"publisher","first-page":"R536","DOI":"10.1016\/j.cub.2021.01.038","volume":"31","author":"MR Chastney","year":"2021","unstructured":"Chastney, M. R., Conway, J. R. W., & Ivaska, J. (2021). Integrin adhesion complexes. Current Biology, 31(10), R536\u2013R542.","journal-title":"Current Biology"},{"issue":"2","key":"1061_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41556-018-0223-z","volume":"21","author":"P Moreno-Layseca","year":"2019","unstructured":"Moreno-Layseca, P., Icha, J., Hamidi, H., & Ivaska, J. (2019). Integrin trafficking in cells and tissues. Nature Cell Biology, 21(2), 122\u2013132.","journal-title":"Nature Cell Biology"},{"issue":"9","key":"1061_CR10","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.apsb.2021.01.004","volume":"11","author":"M Li","year":"2021","unstructured":"Li, M., Wang, Y., Li, M., Wu, X., Setrerrahmane, S., & Xu, H. (2021). Integrins as attractive targets for cancer therapeutics. Acta Pharmaceutica Sinica B, 11(9), 2726\u20132737.","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"4","key":"1061_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrm3769","volume":"15","author":"SE Winograd-Katz","year":"2014","unstructured":"Winograd-Katz, S. E., Fassler, R., Geiger, B., & Legate, K. R. (2014). The integrin adhesome: From genes and proteins to human disease. Nature Reviews Molecular Cell Biology, 15(4), 273\u2013288.","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"1061_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12935-020-01307-7","volume":"20","author":"J Li","year":"2020","unstructured":"Li, J., Hao, N., Han, J., Zhang, M., Li, X., & Yang, N. (2020). ZKSCAN3 drives tumor metastasis via integrin beta4\/FAK\/AKT mediated epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Cell International, 20, 216.","journal-title":"Cancer Cell International"},{"issue":"21","key":"1061_CR13","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.7150\/jca.29269","volume":"10","author":"M Li","year":"2019","unstructured":"Li, M., Jiang, X., Wang, G., Zhai, C., Liu, Y., Li, H., Zhang, Y., Yu, W., & Zhao, Z. (2019). ITGB4 is a novel prognostic factor in colon cancer. Journal of Cancer, 10(21), 5223\u20135233.","journal-title":"Journal of Cancer"},{"issue":"3","key":"1061_CR14","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41388-019-1014-0","volume":"39","author":"JS Sung","year":"2020","unstructured":"Sung, J. S., Kang, C. W., Kang, S., Jang, Y., Chae, Y. C., Kim, B. G., & Cho, N. H. (2020). ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts. Oncogene, 39(3), 664\u2013676.","journal-title":"Oncogene"},{"issue":"2","key":"1061_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112055","volume":"392","author":"EJ Wilkinson","year":"2020","unstructured":"Wilkinson, E. J., Woodworth, A. M., Parker, M., Phillips, J. L., Malley, R. C., Dickinson, J. L., & Holloway, A. F. (2020). Epigenetic regulation of the ITGB4 gene in prostate cancer. Experimental Cell Research, 392(2), 112055.","journal-title":"Experimental Cell Research"},{"key":"1061_CR16","doi-asserted-by":"publisher","first-page":"8571932","DOI":"10.1155\/2020\/8571932","volume":"2020","author":"S Zhang","year":"2020","unstructured":"Zhang, S., Lu, Y., Qi, L., Wang, H., Wang, Z., & Cai, Z. (2020). AHNAK2 is associated with poor prognosis and cell migration in lung adenocarcinoma. BioMed Research International, 2020, 8571932.","journal-title":"BioMed Research International"},{"issue":"5","key":"1061_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y., & He, Q. Y. (2012). clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS: A Journal of Integrative Biology, 16(5), 284\u2013287.","journal-title":"OMICS: A Journal of Integrative Biology"},{"issue":"1","key":"1061_CR18","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021). Cancer statistics, 2021. CA: A Cancer Journal for Clinicians, 71(1), 7\u201333.","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1","key":"1061_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10555-016-9618-0","volume":"35","author":"HH Popper","year":"2016","unstructured":"Popper, H. H. (2016). Progression and metastasis of lung cancer. Cancer and Metastasis Reviews, 35(1), 75\u201391.","journal-title":"Cancer and Metastasis Reviews"},{"issue":"1","key":"1061_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2012.12.007","volume":"87","author":"F Perlikos","year":"2013","unstructured":"Perlikos, F., Harrington, K. J., & Syrigos, K. N. (2013). Key molecular mechanisms in lung cancer invasion and metastasis: A comprehensive review. Critical Reviews in Oncology Hematology, 87(1), 1\u201311.","journal-title":"Critical Reviews in Oncology Hematology"},{"key":"1061_CR21","unstructured":"Jamil, A., & Kasi, A. (2022). Lung metastasis StatPearls. Treasure Island (FL)"},{"issue":"4","key":"1061_CR22","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1158\/0008-5472.CAN-19-1145","volume":"80","author":"S Ruan","year":"2020","unstructured":"Ruan, S., Lin, M., Zhu, Y., Lum, L., Thakur, A., Jin, R., Shao, W., Zhang, Y., Hu, Y., Huang, S., Hurt, E. M., Chang, A. E., Wicha, M. S., & Li, Q. (2020). Integrin beta4-targeted cancer immunotherapies inhibit tumor growth and decrease metastasis. Cancer Research, 80(4), 771\u2013783.","journal-title":"Cancer Research"},{"issue":"5","key":"1061_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/PAS.0000000000001451","volume":"44","author":"J Li","year":"2020","unstructured":"Li, J., Jiang, Y., Chen, C., Tan, W., Li, P., Chen, G., Peng, Q., & Yin, W. (2020). Integrin beta4 is an effective and efficient marker in synchronously highlighting lymphatic and blood vascular invasion, and perineural aggression in malignancy. American Journal of Surgical Pathology, 44(5), 681\u2013690.","journal-title":"American Journal of Surgical Pathology"},{"issue":"13","key":"1061_CR24","doi-asserted-by":"publisher","first-page":"9835","DOI":"10.1074\/jbc.M111.317727","volume":"287","author":"KD Gerson","year":"2012","unstructured":"Gerson, K. D., Shearstone, J. R., Maddula, V., Seligmann, B. E., & Mercurio, A. M. (2012). Integrin beta4 regulates SPARC protein to promote invasion. Journal of Biological Chemistry, 287(13), 9835\u20139844.","journal-title":"Journal of Biological Chemistry"},{"issue":"12","key":"1061_CR25","doi-asserted-by":"publisher","first-page":"E2337","DOI":"10.1073\/pnas.1618298114","volume":"114","author":"B Bierie","year":"2017","unstructured":"Bierie, B., Pierce, S. E., Kroeger, C., Stover, D. G., Pattabiraman, D. R., Thiru, P., Liu Donaher, J., Reinhardt, F., Chaffer, C. L., Keckesova, Z., & Weinberg, R. A. (2017). Integrin-beta4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells. Proc Natl Acad Sci USA, 114(12), E2337\u2013E2346.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1061_CR26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/labinvest.2014.166","volume":"95","author":"Y Masugi","year":"2015","unstructured":"Masugi, Y., Yamazaki, K., Emoto, K., Effendi, K., Tsujikawa, H., Kitago, M., Itano, O., Kitagawa, Y., & Sakamoto, M. (2015). Upregulation of integrin beta4 promotes epithelial-mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma. Laboratory Investigation, 95(3), 308\u2013319.","journal-title":"Laboratory Investigation"},{"issue":"1","key":"1061_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-019-1034-1","volume":"38","author":"B Ma","year":"2019","unstructured":"Ma, B., Zhang, L., Zou, Y., He, R., Wu, Q., Han, C., & Zhang, B. (2019). Reciprocal regulation of integrin beta4 and KLF4 promotes gliomagenesis through maintaining cancer stem cell traits. Journal of Experimental & Clinical Cancer Research, 38(1), 23.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"8","key":"1061_CR28","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1158\/1541-7786.MCR-21-0994","volume":"20","author":"SH Choi","year":"2022","unstructured":"Choi, S. H., Kim, J. K., Chen, C. T., Wu, C., Marco, M. R., Barriga, F. M., O\u2019Rourke, K., Pelossof, R., Qu, X., Chang, Q., de Stanchina, E., Shia, J., Smith, J. J., Sanchez-Vega, F., & Garcia-Aguilar, J. (2022). KRAS mutants upregulate integrin beta4 to promote invasion and metastasis in colorectal cancer. Molecular Cancer Research, 20(8), 1305\u20131319.","journal-title":"Molecular Cancer Research"},{"issue":"3","key":"1061_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.103481","volume":"28","author":"MA Khan","year":"2022","unstructured":"Khan, M. A., & Tania, M. (2022). Cordycepin and kinase inhibition in cancer. Drug Discovery Today, 28(3), 103481.","journal-title":"Drug Discovery Today"},{"issue":"1","key":"1061_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.86","volume":"6","author":"B Xu","year":"2017","unstructured":"Xu, B., Lefringhouse, J., Liu, Z., West, D., Baldwin, L. A., Ou, C., Chen, L., Napier, D., Chaiswing, L., Brewer, L. D., St Clair, D., Thibault, O., van Nagell, J. R., Zhou, B. P., Drapkin, R., Huang, J. A., Lu, M. L., Ueland, F. R., & Yang, X. H. (2017). Inhibition of the integrin\/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy. Oncogenesis, 6(1), e295.","journal-title":"Oncogenesis"},{"issue":"1","key":"1061_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.canlet.2016.03.023","volume":"376","author":"C Leng","year":"2016","unstructured":"Leng, C., Zhang, Z. G., Chen, W. X., Luo, H. P., Song, J., Dong, W., Zhu, X. R., Chen, X. P., Liang, H. F., & Zhang, B. X. (2016). An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway. Cancer Letters, 376(1), 188\u2013196.","journal-title":"Cancer Letters"},{"issue":"6","key":"1061_CR32","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/onc.2017.363","volume":"37","author":"L Gan","year":"2018","unstructured":"Gan, L., Meng, J., Xu, M., Liu, M., Qi, Y., Tan, C., Wang, Y., Zhang, P., Weng, W., Sheng, W., Huang, M., & Wang, Z. (2018). Extracellular matrix protein 1 promotes cell metastasis and glucose metabolism by inducing integrin beta4\/FAK\/SOX2\/HIF-1alpha signaling pathway in gastric cancer. Oncogene, 37(6), 744\u2013755.","journal-title":"Oncogene"},{"issue":"30","key":"1061_CR33","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1038\/s41388-018-0252-x","volume":"37","author":"S Wang","year":"2018","unstructured":"Wang, S., Li, J., Xie, J., Liu, F., Duan, Y., Wu, Y., Huang, S., He, X., Wang, Z., & Wu, X. (2018). Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin beta4\/SNAI1\/SIRT3 signaling pathway. Oncogene, 37(30), 4164\u20134180.","journal-title":"Oncogene"},{"issue":"1","key":"1061_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13046-018-0850-z","volume":"37","author":"J Shen","year":"2018","unstructured":"Shen, J., Cao, B., Wang, Y., Ma, C., Zeng, Z., Liu, L., Li, X., Tao, D., Gong, J., & Xie, D. (2018). Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1\/FAK signalling in breast cancer. Journal of Experimental & Clinical Cancer Research, 37(1), 175.","journal-title":"Journal of Experimental & Clinical Cancer Research"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01061-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01061-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01061-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T12:10:15Z","timestamp":1736338215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01061-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1061"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01061-5","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]},"assertion":[{"value":"7 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The study was approved by the Ethics Committee of affiliated Xing Tai People Hospital of Hebei Medical University. All methods in this study were performed in accordance with the relevant guidelines and regulations. The study is reported in accordance with ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}